Do non-targeted gastric biopsies affect the management of patients, and can a simple protocol and education reduce the rate?
Sign Up to like & getrecommendations! Published in 2017 at "Frontline Gastroenterology"
DOI: 10.1136/flgastro-2017-100813
Abstract: Objective To determine whether development of localised protocol could reduce the number of non-targeted gastric biopsies taken at endoscopy, without risking harm from non-detection of malignant conditions. Design Retrospective analysis of patient records over a… read more here.
Keywords: histopathology; management; targeted gastric; non targeted ... See more keywords
Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy
Sign Up to like & getrecommendations! Published in 2017 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s140797
Abstract: For targeted gastric carcinoma therapy, hyaluronic acid (HA)-modified layer-by-layer nanoparticles (NPs) are applied for improving anticancer treatment efficacy and reducing toxicity and side effects. The aim of this study was to develop HA-modified NPs for… read more here.
Keywords: gastric carcinoma; carcinoma; layer; targeted gastric ... See more keywords